EKSO
Ekso Bionics·NASDAQ
--
--(--)
--
--(--)
5.62 / 10
Netural
Money flow analysis registers 7.63/10, showing robust fund flow characteristics. Positive momentum in no significant trends is countered by negative tendencies in overall, block, Small, Medium, Large, and Extra-large, suggesting positive flow conditions. Analyst coverage indicates divided analyst consensus with neutral perspective.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-31
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate75.0%
Is money flowing into or out of EKSO?
- EKSO holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.62/10 (Netural).
